The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

According to The Business Research Company’s Flow Cytometry In Oncology And Immunology Global Market Report 2024, the flow cytometry in oncology and immunology market is expected to show promising growth in the forecast period.

Rapid Growth Forecasted

• Market size projected to reach $2.1 billion in 2024.
• Compound Annual Growth Rate (CAGR) of 10.9% from 2023.
• Expected to surge to $3.07 billion by 2028, with a CAGR of 10.0%.

Drivers of Growth

• Advancements in cancer and immunology research.
• Increased diagnostic applications.
• Surge in autoimmune diseases.
• Intensifying drug development and clinical trials.

View More On The Flow Cytometry In Oncology And Immunology Market Report 2024 – https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report

Anticipated Surge: Cancer Prevalence

• Rising cancer incidence propels market growth.
• Flow cytometry crucial for cancer and immune cell analysis.
• Macmillan Cancer Support projects significant increase in cancer cases by 2040.

Key Players

• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Merck KGaA
• Becton Dickinson and Company
• Laboratory Corporation of America Holdings
• Agilent Technologies Inc.
• Sartorius AG
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• Sysmex Partec GmbH
• And many more.

Technological Advancements

• Companies integrating new technologies.
• Example: Becton Dickinson’s BD Research Cloud.
• BD Cloud simplifies flow cytometry processes.
• Leveraging innovative technologies for enhanced studies.

DiaSorin’s Strategic Move

• Acquisition of Luminex Corporation for $1.8 billion.
• Enhances DiaSorin’s portfolio in life science sector.
• Strengthens collaboration with biopharma businesses.

Market Segmentation

1. By Type:
   • Immunology
   • Oncology
2. By Technology:
   • Cell-Based Flow Cytometry
   • Bead-Based Flow Cytometry
3. By Application:
   • Translational Research
   • Clinical Research
4. By End User:
   • Hospitals
   • Diagnostic Laboratories
   • Reference Laboratories
   • Pharmaceutical and Biotechnology Companies
   • Academic Research Institutes
   • Contract Research Organizations
   • Other End Users

Regional Dominance

• North America led the market in 2023.
• High adoption rate of flow cytometry in oncology and immunology.

Conclusion The exponential growth of flow cytometry in oncology and immunology signifies its crucial role in advancing cancer and immunological research. With technological innovations, strategic acquisitions, and rising cancer prevalence, the market is poised for substantial expansion. Collaboration among key players and continuous advancements in technology are expected to drive the market forward, facilitating more effective diagnosis and treatment strategies for cancer and immune-related diseases.

Request A Sample Of The Global Flow Cytometry In Oncology And Immunology Market Report 2024:
https://www.thebusinessresearchcompany.com/sample_request?id=12469&type=smp